Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The thrombopoietic factor, Mpl-ligand

J E Rasko1, C G Begley

  • 1Walter and Eliza Hall Institute of Medical Research, Post Office Royal Melbourne Hospital, Parkville, Victoria, Australia. jrasko@fred.fhcrc.org

The International Journal of Biochemistry & Cell Biology
|August 8, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dynamics of Fluorescent Imaging for Rapid Tear Thinning.

Bulletin of mathematical biology·2018
Same author

Mathematical modelling of glob-driven tear film breakup.

Mathematical medicine and biology : a journal of the IMA·2018
Same author

Bivalent IAP antagonists, but not monovalent IAP antagonists, inhibit TNF-mediated NF-<i>κ</i>B signaling by degrading TRAF2-associated cIAP1 in cancer cells.

Cell death discovery·2017
Same author

Dynamics and function of the tear film in relation to the blink cycle.

Progress in retinal and eye research·2014
Same author

Reporters of gene expression: autofluorescent proteins.

Current protocols in cytometry·2008
Same author

Induced dystrophin exon skipping in human muscle explants.

Neuromuscular disorders : NMD·2006
Same journal

Corrigendum to "Sodium butyrate down-regulation of indoleamine 2, 3-dioxygenase at the transcriptional and post-transcriptional levels" [Int. J. Biochem. Cell Biol. 42 (2010) 1840-1846].

The international journal of biochemistry & cell biology·2026
Same journal

Whole-brain spatial metabolomics reveals metabolic gradient shifts in a murine glioma model following boron neutron capture therapy (130 characters).

The international journal of biochemistry & cell biology·2026
Same journal

LCN2 modulates Th17/Treg balance in vitro and is associated with an adaptive response to intestinal ischemia-reperfusion injury under Hmox1-deficient conditions.

The international journal of biochemistry & cell biology·2026
Same journal

Chloroquine modulates the redox-sensitive signalling via inhibiting the AMPK-ULK1 under LPS induced state in murine splenic macrophages.

The international journal of biochemistry & cell biology·2026
Same journal

The vicious cycle of hyperglycemia and oxidative stress: Novel mechanistic insights into a pathogenic alliance.

The international journal of biochemistry & cell biology·2026
Same journal

Fibroblast growth factors (FGF) in the pathogenesis and treatment of inflammatory bowel diseases (IBD): An overview.

The international journal of biochemistry & cell biology·2026
See all related articles

Mpl-ligand, also known as thrombopoietin (TPO), promotes the growth and maturation of megakaryocyte lineage cells. This agent shows promise in increasing platelet counts and aiding recovery after chemotherapy in oncology.

Area of Science:

  • Hematology
  • Molecular Biology
  • Oncology

Background:

  • Mpl-ligand, including thrombopoietin (TPO) and Megakaryocyte growth and development factor (MGDF), was identified after the mpl oncogene discovery.
  • The mpl oncogene encodes a truncated receptor within the hemopoietin-receptor superfamily.
  • Mpl-ligand possesses a two-domain structure, with an active amino-terminal domain homologous to erythropoietin.

Purpose of the Study:

  • To investigate the role of Mpl-ligand in megakaryocyte proliferation and maturation.
  • To evaluate the potential of Mpl-ligand in enhancing platelet recovery post-chemotherapy.
  • To explore the broader effects of Mpl-ligand on multiple hematopoietic lineages.

Main Methods:

  • Analysis of Mpl-ligand structure and function.

Related Experiment Videos

  • Examination of Mpl-ligand mRNA expression in liver and kidney.
  • Review of pre-clinical and early clinical studies on Mpl-ligand efficacy.

    • Main Results:

    • Mpl-ligand is a potent stimulator of megakaryocyte proliferation and maturation.
    • Mpl-ligand influences progenitor/stem cells across multiple hematopoietic lineages.
    • Pre-clinical and clinical data indicate Mpl-ligand increases platelet counts and accelerates recovery after chemotherapy.

    Conclusions:

    • Mpl-ligand demonstrates significant potential as a therapeutic agent in clinical oncology.
    • Its ability to enhance platelet production offers promise for managing chemotherapy-induced thrombocytopenia.
    • Further clinical studies are warranted to fully establish its therapeutic value.